Skip to content

Drug interactions

Elagolix + Pantoprazole

Severity: Minor

Elagolix and Pantoprazole: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix is a weak CYP2C19 inhibitor and may modestly raise pantoprazole concentrations. The effect is unlikely to be clinically important given pantoprazole's wide therapeutic margin.

What this interaction means in plain words

Elagolix and Pantoprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Elagolix belongs to Musculoskeletal; Pantoprazole belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Weak inhibition of CYP2C19 by elagolix reduces pantoprazole metabolism.

What to do

No dose change is usually required. Be aware of possible increased PPI adverse effects with long-term co-use.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Pantoprazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Pantoprazole?

MediHelp rates the interaction as minor. Elagolix and Pantoprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Elagolix is a weak CYP2C19 inhibitor and may modestly raise pantoprazole concentrations. The effect is unlikely to be clinically important given pantoprazole's wide therapeutic margin.

How serious is the interaction between Elagolix and Pantoprazole?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually required. Be aware of possible increased PPI adverse effects with long-term co-use.

What other medicines interact with Pantoprazole?

MediHelp also lists interactions of Pantoprazole with, for example, Rilpivirine, Acalabrutinib, Atazanavir. The full list is on the Pantoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in